Comparison of automated culture systems with a CFR/USP-compliant method for sterility testing of cell-therapy products

Cytotherapy

Volumn 6, Issue 3, 2004, Pages 183-195

  Khuu, Hanh M ^a   Stock, F ^a   McGann, M ^a   Carter, C S ^a   Atkins, J W ^a   Murray, P R ^a   Read, E J ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Cell therapy products; Somatic cell therapy; Sterility testing

Indexed keywords

ANTIBIOTIC AGENT;

ADOPTIVE IMMUNOTHERAPY; AEROBIC CELL CULTURE; ANAEROBIC CELL CULTURE; ANALYTIC METHOD; ANTIFUNGAL ACTIVITY; ARTICLE; ASEPSIS; ASPERGILLUS NIGER; AUTOMATION; BACILLUS SUBTILIS; BACTERIOSTASIS; CANDIDA ALBICANS; CELL CULTURE; CLOSTRIDIUM SPOROGENES; COLONY FORMING UNIT; CONTROLLED STUDY; CULTURE MEDIUM; DRUG SCREENING; FOOD AND DRUG ADMINISTRATION; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; KLEBSIELLA PNEUMONIAE; LEUKAPHERESIS; MICROCOCCUS LUTEUS; MICROORGANISM DETECTION; MONONUCLEAR CELL; NORMAL HUMAN; PROPIONIBACTERIUM ACNES; PSEUDOMONAS AERUGINOSA; PUBLIC HEALTH SERVICE; STANDARD; STAPHYLOCOCCUS AUREUS; TIME; UNITED STATES; VOLUNTEER; YERSINIA ENTEROCOLITICA;

EID: 3042808738     PISSN: 14653249     EISSN: None     Source Type: Journal    
DOI: 10.1080/14653240410005997     Document Type: Article

References (30)

1. US Food and Drug Administration. Suitability determination for donors of human cellular and tissue-based products; Proposed rule. Federal Register 1999;64:52696-723.
2. US Food and Drug Administration. General Biologics Standards. 21 CFR 600.
3. Read EJ. The new regulatory environment for cellular therapy products: challenges for academic-based manufacturing facilities. In: Smit Sibinga CTh, de Leij LFMH, editors. Cellular engineering and cellular therapies. Boston: Kluwer Academic Publishers, 2003.
4. Burger S. Current regulatory issues in cell and tissue therapy. Cytotherapy 2003;5:289-98.
5. US Food and Drug Administration. General Biologics Standards. 21 CFR 610.12.
6. US Pharmacopeia. General Information Chapter 71, Sterility Tests, Rockville, MD 2003.
7. Reimer LG, Wilson ML, Weinstein MP. Update on detection of bacteremia and fungemia. Clin Microbiol Rev 1997;10:44-465.
8. Bourbeau P, Riley J, Heiter BJ et al. Use of the BacT/Alert blood culture system for culture of sterile body fluids other than blood. J Clin Microbiol 1998;36:3273-7.
9. Simor AE, Scythes K, Meaney H et al. Evaluation of the BacT/Alert microbial detection system with FAN aerobic and FAN anaerobic bottles for culturing normally sterile body fluids other than blood. Diagn Microbiol Infect Dis 2000;37:5-9.
10. Fuller DD, Davis TE. Comparison of Bactec Plus Aerobic/F, Anaerobic/F, Peds Plus/F, and Lytic/F media with and without fastidious organism supplement to conventional methods for culture of sterile body fluids. Diagn Microbiol Infect Dis 1997;29:219-25.
11. Davis-Sproul J. ISCT sterility testing survey. ISCT Telegraft Newsletter 2002;9:1-3.
12. Red cell transfusions contaminated with Yersinia enterocolitica - United States, 1991 - 1996, and initiation of a national study to detect bacteria-associated transfusion reactions. MMWR 1997; 46:553-5.
13. Crepin O, Roussel-Delvallez M, Martin GR et al. Effectiveness of resins in removing antibiotics from blood cultures. J Clin Microbiol 1993;31:734-5.
14. Lindsey NJ, Riely PE. In vitro antibiotic removal and bacterial recovery from blood with an antibiotic removal device. J Clin Microbiol 1981;13:503-7.
15. Smith SM, Eng RK. In vitro evaluation of the Bactec resin-containing blood culture bottle. J Clin Microbiol 1983;17:1120-6.
16. Spaargaren J, van Boven CPA, Voorn GP. Effectiveness of resins in neutralizing antibiotic activities in Bactec Plus Aerobic/F culture media. J Clin Microbiol 1998;36:3731-3.
17. Rowley SD, Davis J, Dick J et al. Bacterial contamination of bone marrow grafts intended for autologous and allogeneic bone marrow transplantation. Transfusion 1988;28:109-12.
18. Stroncek DF, Fautsch DK, Lasky LC et al. Adverse reactions in patients transfused with cryopreserved marrow. Transfusion 1991;31:512-26.
19. Lazarus HM, Magalhaes-Silverman M, Fox RM et al. Contamination during in vitro processing of bone marrow for transplantation: clinical significance. Bone Marrow Transplant 1991;7:241-6.
20. Schwella N, Zimmermann R, Heuft HG et al. Microbiologic contamination of peripheral blood stein cell autografts. Vox Sang 1994;67:32-5.
21. Prince HM, Page SR, Keating A et al. Microbial contamination of harvested bone marrow and peripheral blood. Bone Marrow Transplant 1995;15:87-91.
22. Padley D, Koontz F, Trigg ME et al. Bacterial contamination rates following processing of bone marrow and peripheral blood progenitor cell preparations. Transfusion 1996;36:53-9.
23. Webb IJ, Coral FS, Andersen JW et al. Sources and sequelae of bacterial contamination of hematopoietic stem cell components: implications for the safety of hematotherapy and graft engineering. Tranfusion 1996;36:782-8.
24. Espinosa MTF, Fox R, Creger RJ et al. Microbiologic contamination of peripheral blood progenitor cells collected for hematopoietic cell transplantation. Transfusion 1996;36:789-93.
25. Khuu HM, Cowley H, David-Ocampo V et al. Catastrophic failures of freezing bags for cellular therapy products: description, cause, and consequences. Cytotherapy 2002;4:539-49.
26. Kocka FE, Magoc T, Searcy RL. Action of sulfated polyanions used in blood culture on lysozyme, complement and antibiotics. Ann Clin Lab Sci 1972;2:470-3.
27. Krogstad D, Murray P, Granich G et al. Sodium polyanethol-sulfonate (SPS) inactivation of aminoglycosides. Antimicrob Agents Chemother 1981;20:66-70.
28. Murray P, Niles A. Inactivation of penicillins by thiol broth. J Clin Microbiol 1982;16:982-4.
29. Brecher ME, Means N, Jere CS et al. Evaluation of an automated culture system for detecting bacterial contamination of platelets: an analysis with 15 contaminating organisms. Transfusion 2001;41:477-82.
30. US Pharmacopeia. General Information Chapter 1046, Cell and Gene Therapy, Rockville, MD 2003.